Elevated Plasma Levels of Urokinase Plasminogen Activator Receptor in Non-small Cell Lung Cancer Patients

By Pappot H.   Hoyer-Hansen G.   Ronne E.   Hansen H.H.   Brunner N.   Dano K.   Grondahl-Hansen J.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 867-872

Elsevier

Access to resources Recommend Favorite

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

By Chung Hyun   Rha Sun   Park Joon   Yoo Nae   Kim Joo   Roh Jae   Min Jin   Lee Kyong   Kim Byung   Kim Jin  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 41-50

Springer Publishing Company

Access to resources Recommend Favorite

Disregulation of Urokinase Plasminogen Activator Gene in Breast Cancer

By Hubbard A.L.   Lauder J.   Hawkins R.A.   Anderson T.J.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 103-107

Elsevier

Access to resources Recommend Favorite

Soluble Urokinase Plasminogen Activator Receptor in Preoperatively Obtained Plasma from Patients with Gynecological Cancer or Benign Gynecological Diseases

By Riisbro R.   Stephens R.W.   Brunner N.   Christensen I.J.   Nielsen H.J.   Heilmann L.   von Tempelhoff G.-F.  

Gynecologic Oncology, Vol. 82, Iss. 3, 2001-09 ,pp. : 523-531

Elsevier

Access to resources Recommend Favorite

Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients

By Lomholt Anne Fog   Christensen Ib J.   Høyer-Hansen Gunilla   Nielsen Hans J.  

Acta Oncologica, Vol. 49, Iss. 6, 2010-08 ,pp. : 805-811

Informa Healthcare

Access to resources Recommend Favorite